Hypermethylation of the p15INK4B Gene in Myelodysplastic Syndromes
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Previous studies have shown that the cyclin-dependent kinase inhibitor (CDKI) genes p15INK4B and p16INK4A are frequently inactivated by genetic alterations in many malignant tumors and that they are candidate tumor-suppressor genes. Although genetic alterations in these genes may be limited to lymphoid malignancies, it has been reported that their inactivation by aberrant methylation of 5′ CpG islands may be involved in various hematologic malignancies. In this study, we investigated the p15INK4B and p16INK4A genes to clarify their roles in the pathogenesis of myelodysplastic syndrome (MDS). Southern blotting analysis showed no gross genetic alterations in either of these genes. However, hypermethylation of the 5′ CpG island of the p15INK4B gene occurred frequently in patients with MDS (16/32 [50%]). Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]). Furthermore, methylation status of the p15INK4B gene was progressed with the development of MDS in most patients examined. In contrast, none of the MDS patients showed apparent hypermethylation of the p16INK4A gene. These results suggest that hypermethylation of the p15INK4B gene is involved in the pathogenesis of MDS and is one of the important late events during the development of MDS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Bennett, J. M., Catovsky, D., Daniel, M., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb03563.x · Cited by 5,602
International scoring system for evaluating prognosis in myelodysplastic syndromes
Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Proposals for the classification of the myelodysplastic syndromes
Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1982) · British Journal of Haematology · doi:10.1111/j.1365-2141.1982.tb08475.x · Cited by 3,627
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,986
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
Issa, J.-P. J., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., & Baylin, S. B. (1994) · Nature Genetics · doi:10.1038/ng0894-536 · Cited by 1,191
The essentials of DNA methylation
Bird, A. (1992) · Cell · doi:10.1016/0092-8674(92)90526-i · Cited by 948
Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
Herman, J. G., Jen, J., Merlo, A. U., & Baylin, S. B. (1996) · PubMed · Cited by 571
Boyes, J., & Bird, A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05055.x · Cited by 471
Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene.
Sakai, T., Toguchida, J., Ohtani, N., Yandell, D. W., Rapaport, J. M., & Dryja, T. P. (1991) · PubMed · Cited by 466
DNA methylation errors and cancer.
Jones, P. A. (1996) · PubMed · Cited by 454
Role of the cyclin-dependent kinase inhibitors in the development of cancer
Hirama, T., & Koeffler, H. (1995) · Blood · doi:10.1182/blood.v86.3.841.841 · Cited by 418
Herman, J. G., Civin, C. I., Issa, J. J., Collector, M. I., Sharkis, S. J., & Baylin, S. B. (1997) · PubMed · Cited by 405
Kinoshita, T., Shimoyama, M., Tobinai, K., Ito, M., Ito, S., Ikeda, S., Tajima, K., Shimotohno, K., & Sugimura, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.14.5620 · Cited by 282
Self-citationAlterations in DNA methylation may play a variety of roles in carcinogenesis
Counts, J. L., & Goodman, J. I. (1995) · Cell · doi:10.1016/0092-8674(95)90228-7 · Cited by 219
Frequent Hypermethylation of p16 and p15 Genes in Multiple Myeloma
Ng, M. H. L., Chung, Y. F., Lo, K. W., Wickham, N. W. R., Lee, J. C. K., & Huang, D. P. (1997) · Blood · doi:10.1182/blood.v89.7.2500 · Cited by 187
Singer-Sam, J., Grant, M., LeBon, J. M., Okuyama, K., Chapman, V, Monk, M., & Riggs, A. D. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.9.4987 · Cited by 178
Batova, A., Diccianni, M. B., Yu, J., Nobori, T., Link, M. P., Pullen, J., & Yu, A. L.-T. (1997) · PubMed · Cited by 164
Mutations of p53 gene and their relation to disease progression in B- cell lymphoma
Ichikawa, A., Hotta, T., Takagi, N., Tsushita, K., Kinoshita, T., Nagai, H., Murakami, Y., Hayashi, K., & Saito, H. (1992) · Blood · doi:10.1182/blood.v79.10.2701.2701 · Cited by 163
Self-citationGenomic structure, expression and mutational analysis of the P15 (MTS2) gene.
Stone, S., Dayananth, P., Jiang, P., Weaver-Feldhaus, J., Tavtigian, S. V., Cannon‐Albright, L., & Kamb, A. (1995) · PubMed · Cited by 103
Research, U. K. L. U. (1996) · Lung Cancer · doi:10.1016/s0169-5002(97)89504-9 · Cited by 103
Delforge, M., Demuynck, H., Vandenberghe, P., Verhoef, G. E. G., Zachée, P., Duppen, V. V., Marijnen, P., BERGHE, H. V. D., & Boogaerts, M. (1995) · Blood · doi:10.1182/blood.v86.10.3660.bloodjournal86103660 · Cited by 78
Nakamaki, T., Kawamata, N., Schwaller, J., Tobler, A., Fey, M., Pakkala, S., Lee, Y. Y., Kim, B. K., Fukuchi, K., Tsuruoka, N., et al. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05259.x · Cited by 48
Asano, H., Ohashi, H., Ichihara, M., Kinoshita, T., Murate, T., Kobayashi, M., Saito, H., & Hotta, T. (1994) · Blood · doi:10.1182/blood.v84.2.588.588 · Cited by 48
Self-citationIto, T., Ohashi, H., Kagami, Y., ICHIKAWA, A., Saito, H., & Hotta, T. (1994) · PubMed · Cited by 35
Self-citationOhashi, H., Ichikawa, A., Takagi, N., Hotta, T., Naoe, T., Ohno, R., & SAITO, H. (1992) · PubMed · Cited by 33
Self-citationMutational analysis of the p15 and p16 genes in acute leukaemias
Sill, H., Aguiar, R. C. T., Schmidt, H., Hochhaus, A., Goldman, J. M., & Cross, N. C. P. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.340858.x · Cited by 22
CDKN2 (MTS1/p16 INK4A ) Gene Alterations in Hematological Malignancies
Uchida, T., Kinoshita, T., Saito, H., & Hotta, T. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709055583 · Cited by 18
Self-citation
Cited by
Silverman, L. R., Demakos, E. P., Peterson, B. L., Kornblith, A. B., Holland, J. C., Odchimar-Reissig, R., Stone, R. M., Nelson, D., Powell, B. L., DeCastro, C. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.117 · Cited by 1,825
Das, P. M., & Singal, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.151 · Cited by 1,456
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009
Daskalakis, M., Nguyen, T. T., Nguyen, C., Guldberg, P., Köhler, G., Wijermans, P., Jones, P. A., & Lübbert, M. (2002) · Blood · doi:10.1182/blood.v100.8.2957 · Cited by 514
FDA Drug Approval Summary: Azacitidine (5-azacytidine, Vidaza™) for Injectable Suspension
Kaminskas, E., Farrell, A. T., Wang, Y.-C., Sridhara, R., & Pazdur, R. (2005) · The Oncologist · doi:10.1634/theoncologist.10-3-176 · Cited by 490
Metadata
- Authors
- Uchida, T., Kinoshita, T., Nagai, H., Nakahara, Y., Saito, H., Hotta, T., & Murate, T.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1997-08-15
- Volume
- 90
- Issue
- 4
- Pages
- 1403-1409
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2354344320
- Cited by
- 269
- References
- 34
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.